Blueberries Medical Corp.
BBRRF
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.43M
Close$
$-0.01
177% downside
Current Fair Value
177% downsideOvervalued by 177% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.43 Million |
|---|---|
| Enterprise Value | $7.42 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 2.65 |
| Outstanding Shares | 495,090,087 |
Return
| Return on Equity | -3706.26% |
|---|---|
| Return on Assets | -158.50% |
| Return on Invested Capital | -2583.82% |
Valuation & Multiples
| P/E Ratio | -7.14 |
|---|---|
| PEG | -325.49 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 26.78 |
| Enterprise Value to EBIT | -10.02 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Blueberries Medical Corp.
51 employees
CEO: Facundo Garreton Headquartered in Bogotá, Colombia, Blueberries Medical Corp. operates within the medicinal cannabis industry. The company's activities encompass the entire process, from cultivating and developing to producing and supplying medical-grade...